Validated capability from Product Development to GMP-approved Commercial Manufacturing
At Adare Pharma Solutions, our goal is to provide peace of mind by leveraging decades of expertise gained from working in the contract drug development and manufacturing (CDMO) space. Our three facilities are cGMP certified, FDA inspected and large enough to accommodate commercial-scale projects.
Adare creates a seamless transition at each stage of drug product development and manufacturing. In addition to our highly experienced team, we offer a number of drug development technologies that facilitate the commercialization of safe pharmaceutical products.
We deliver a comprehensive suite of services that are built to guide you from proof of concept to commercialization. Our integrated service teams are equipped with experienced, trusted leaders from the top pharmaceutical companies. From drug development to scale-up through packaging, we are ready to support you with efficiency in every part of your drug product development.
Our Product Development team includes specialists in technology innovation, formulation, analytical method development and technical services. We have helped dozens of customers like you optimize processes, develop formulations, manage their supply chains, and launch their products.
- Formulation development
- Support including physical characterization
- Analytical Method Development & Validation
- IMPD Manufacture and QP release
- Tech Transfer
- ICH stability programs at all conditions
- Efficient product development pathways for NCEs, ANDA, 505(b)(2), IND/NDAs, and novel delivery systems
- Preclinical to clinical to commercial capability
- IVIVC-based modified release dosage form development
Speak With An Expert
Giuseppe Di Vincenzo
Chief Strategy Officer
Giuseppe leads our strategy, communications and internal pipeline development teams.
He was previously Vice President, Strategic and Commercial Development at Adare where he was responsible for commercial strategy, marketing, business development and internal pipeline development activities. Prior to that, he was Vice President Global Sales and Strategy at Aptalis Pharmaceutical Technologies. Before joining Aptalis, he held a number of senior positions at Eurand. He also held roles with Élan Corporation and Arthur D. Little.
Giuseppe holds a degree in Biology from the University Federico II of Naples, Italy and a Master of Business Administration from the London Business School, United Kingdom.